Your browser is no longer supported. Please, upgrade your browser.
Settings
ESRX Express Scripts Holding Company daily Stock Chart
ESRX [NASD]
Express Scripts Holding Company
IndexS&P 500 P/E11.04 EPS (ttm)5.44 Insider Own0.30% Shs Outstand594.14M Perf Week-9.20%
Market Cap35.65B Forward P/E7.88 EPS next Y7.61 Insider Trans-1.43% Shs Float593.09M Perf Month-6.40%
Income3.40B PEG0.87 EPS next Q1.32 Inst Own88.00% Short Float5.46% Perf Quarter-15.95%
Sales100.29B P/S0.36 EPS this Y51.40% Inst Trans-0.14% Short Ratio7.34 Perf Half Y-13.79%
Book/sh26.66 P/B2.25 EPS next Y9.89% ROA6.70% Target Price80.26 Perf Year-18.60%
Cash/sh5.18 P/C11.59 EPS next 5Y12.65% ROE21.90% 52W Range63.22 - 80.02 Perf YTD-12.76%
Dividend- P/FCF7.77 EPS past 5Y16.40% ROI12.90% 52W High-25.01% Beta0.93
Dividend %- Quick Ratio0.60 Sales past 5Y16.80% Gross Margin8.60% 52W Low-5.08% ATR1.53
Employees25600 Current Ratio0.80 Sales Q/Q-5.00% Oper. Margin5.10% RSI (14)24.41 Volatility2.22% 1.47%
OptionableYes Debt/Eq0.96 EPS Q/Q106.40% Profit Margin3.40% Rel Volume8.35 Prev Close67.25
ShortableYes LT Debt/Eq0.91 EarningsApr 24 AMC Payout0.00% Avg Volume4.41M Price60.01
Recom2.70 SMA20-9.33% SMA50-11.02% SMA200-15.83% Volume36,844,162 Change-10.77%
Apr-25-17Reiterated Mizuho Neutral $76 → $61
Mar-15-17Downgrade Wells Fargo Market Perform → Underperform
Nov-04-16Upgrade Deutsche Bank Sell → Hold $69 → $70
Aug-02-16Reiterated Mizuho Neutral $77 → $82
Jun-20-16Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-16-16Initiated Bernstein Underperform
Jun-07-16Resumed BofA/Merrill Neutral
Apr-27-16Reiterated FBR Capital Mkt Perform $90 → $75
Mar-16-16Initiated Credit Suisse Outperform
Mar-01-16Downgrade Mizuho Buy → Neutral $77
Feb-22-16Downgrade Deutsche Bank Hold → Sell $93 → $61
Feb-18-16Reiterated Barclays Overweight $102 → $85
Feb-17-16Reiterated Maxim Group Buy $109 → $95
Jan-21-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-19-16Downgrade Leerink Partners Outperform → Mkt Perform
Jan-13-16Reiterated Mizuho Buy $101 → $93
Oct-05-15Reiterated Leerink Partners Outperform $105 → $95
Jul-30-15Reiterated RBC Capital Mkts Outperform $87 → $96
Jul-16-15Initiated Mizuho Buy $98 → $101
Jun-18-15Initiated Oppenheimer Perform
Apr-25-17 06:50PM  [$$] Express Scripts Faces a Future Without Its Biggest Customer The Wall Street Journal -10.77%
05:14PM  Caterpillar and Biogen jump; Express Scripts plunges Associated Press
04:49PM  What Happened in the Stock Market Today Motley Fool
04:26PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Express Scripts Holding Company and Advises Investors with Losses to Contact the Firm Business Wire
04:23PM  Express Scripts is airing dirty laundry in its nasty, very public Anthem divorce MarketWatch
04:10PM  Express Scripts Stock Sliding, Anthem Unlikely to Extend Agreement TheStreet.com
04:04PM  Express Scripts, Teva Pharmaceuticals Drop into Tuesdays 52-Week Low Club 24/7 Wall St.
03:21PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Express Scripts Holding Company Business Wire
12:49PM  Here's Why Express Scripts Holding Company Is Getting Beaten Up Today Motley Fool
12:23PM  PBM Meltdown! Express Scripts Plunges on Anthem Loss Investopedia
11:54AM  5 Things You Need to Know About Express Scripts Losing Anthem Motley Fool
11:50AM  Express Scripts expects to lose its largest client American City Business Journals
11:38AM  [$$] Corporate Feud Exposes Big Profits on Drug Sales The Wall Street Journal
11:10AM  Express Scripts Holding Co. :ESRX-US: Earnings Analysis: Q1, 2017 By the Numbers : April 25, 2017 Capital Cube
11:10AM  Express Scripts seeks cost cuts, M&A as it preps for Anthem loss Reuters
11:09AM  Express Scripts' Anthem Loss Goes Deeper Than Numbers Bloomberg
10:35AM  SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm Business Wire
10:30AM  Analysts Try to Defend Express Scripts After Anthem Contract Loss 24/7 Wall St.
10:26AM  Express Scripts seeks cost cuts, M&A as it preps for Anthem loss Reuters
08:52AM  Express Scripts (ESRX) Earnings Top in Q1, FY17 View Up Zacks
06:57AM  A huge pharma middleman just lost its biggest customer and it shows how drug pricing really works Business Insider
12:49AM  PRESS DIGEST - Wall Street Journal - April 25 Reuters
12:35AM  [$$] Express Scripts Says It Will Lose Anthem, Its Biggest Customer, in 2020 The Wall Street Journal
Apr-24-17 10:01PM  EXPRESS SCRIPTS ALERT: J&W Announces Investigation of Express Scripts; Expects to Lose Biggest Customer, Investors Encouraged to Contact Firm PR Newswire
06:53PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Express Scripts Holding Company and Advises Investors with Losses to Contact the Firm Business Wire
06:51PM  Express Scripts expects to lose biggest customer after 2019 Associated Press
06:45PM  Express Scripts says likely to lose top client Anthem Reuters
06:36PM  One of pharma's biggest middlemen just lost a big customer  and it exposes how the industry works Business Insider
06:35PM  Express Scripts CEO: Would love nothing more than to keep Anthem as client CNBC
05:57PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Express Scripts Holding Co. Investors Business Wire
05:56PM  [$$] Express Scripts Says It Will Lose Anthem in 2020 The Wall Street Journal
05:41PM  After-hours buzz: AA, ESRX, WHR & more CNBC
05:13PM  One of the biggest middlemen in the drug industry is losing its largest customer and the stock is tanking Business Insider
05:00PM  Express Scripts shares drop 11% as Anthem unlikely to renew contract MarketWatch
04:57PM  Express Scripts says Anthem unlikely to renew contract after 2019 Reuters
04:37PM  Express Scripts CEO on Anthem contract: Time to show inve... CNBC Videos
04:08PM  Express Scripts to Lose Top Client Anthem Amid Legal Dispute Bloomberg
04:06PM  Express Scripts provides update on Anthem partnership CNBC Videos
04:01PM  Express Scripts Announces 2017 First Quarter Results; Provides Update on Anthem Relationship and Visibility into Core PBM Business Excluding Contribution from Anthem, Coventry and Catamaran PR Newswire
10:40AM  T-Mobile and 4 More Top Companies Reporting Earnings After the Close on Monday 24/7 Wall St.
09:42AM  3 Healthcare Bargain Stocks You Can Buy Right Now Motley Fool
Apr-21-17 06:01PM  Top Research Reports for Today: VZ, KO, SBUX Zacks
Apr-19-17 09:37AM  Will Express Scripts (ESRX) Q1 Earnings Hold a Surprise? Zacks
Apr-17-17 09:21AM  3 Deeply Discounted Value Stocks on Sale This Spring Motley Fool
Apr-11-17 05:00PM  Express Scripts Holding Company Announces First Quarter 2017 Earnings Conference Call GlobeNewswire
Apr-10-17 08:25AM  Mallinckrodt faces lawsuit from Illinois city American City Business Journals
Apr-06-17 01:33PM  Blame Game Over High Drug Prices Escalates With New Ad Bloomberg
09:15AM  Express Scripts CEO Explains Drug Price Competition Bloomberg
08:05AM  Express Scripts CEO on the steps to stopping rising drug prices Fox Business Videos
Apr-04-17 07:45AM  Mylan Copes With New Lawsuit and EpiPen Recall (MYL) Investopedia
07:00AM  U.S. Workers' Compensation Prescription Drug Spending Decreased 7.6% in 2016 Through Cost-Savings Solutions, Improved Care for Injured Workers PR Newswire
Apr-03-17 03:58PM  Mylan hit with new class action lawsuit over EpiPen pricing Reuters
01:59PM  How one company's DevOps success got them the green light to hire 1000 developers TechRepublic
07:00AM  The cost of cancer: new drugs show success at a steep price Reuters
02:00AM  The cost of cancer: new drugs show success at a steep price Reuters
Apr-02-17 02:01PM  3 Top Specialty Pharma Stocks to Buy in 2017 Motley Fool
Mar-31-17 11:07AM  Drug Middlemen Have Slim Profit Margins -- Just Ask Them Bloomberg
07:00AM  Healthcare: Stock-Picking Increasingly Important as Valuations Rise Morningstar
Mar-30-17 04:12AM  Express Scripts (ESRX) Down 4.9% Since Earnings Report: Can It Rebound? Zacks
04:12AM  Express Scripts (ESRX) Down 4.9% Since Earnings Report: Can It Rebound? at Investopedia
Mar-29-17 08:30AM  Why investors arent more excited about Regenerons new $37,000-a-year drug at MarketWatch
Mar-28-17 12:00PM  Regeneron's New Drug Price Could Disappoint Everyone. Here's Why That's A Good Thing Forbes
Mar-25-17 06:00AM  Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin Business Wire
Mar-24-17 08:57AM  Judge dismisses two Express Scripts claims in Anthem drug pricing lawsuit Reuters
Mar-22-17 04:23PM  My 3 Worst-Performing Stocks -- and Why I Still Own Them at Motley Fool
09:50AM  Is Express Scripts (ESRX) a Great Stock for Value Investors?
Mar-19-17 11:44AM  The 1 Move That Could Obliterate This Leading Marijuana Stock at Motley Fool
Mar-17-17 06:00PM  How do insurers decide what medicines to pay for?
11:22AM  Express Scripts says Amgen data opens door to patients
Mar-15-17 05:17PM  [$$] Express Scripts Stock Hardly Looks Healthy at Barrons.com
04:35PM  Express Scripts Downgraded On Fear It Could Lose Anthem Contract
08:59AM  Morning Movers: Southwestern Energy Soars, Delta Air Lines Dips, MSCI Surges at Barrons.com
07:08AM  Express Scripts downgraded by Wells Fargo
Mar-14-17 04:02PM  A Market of Extremes
Mar-10-17 06:00AM  3 Profitable Healthcare Services Firms at Good Prices at Morningstar
Mar-08-17 05:17PM  Politicians Question EpiPen Competitor's High Pricetag
04:08PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Mar-07-17 01:34PM  Express Scripts Holding Company to Present at the Barclays Global Healthcare Conference PR Newswire
08:55AM  Express Scripts Holding Co. breached its 50 day moving average in a Bearish Manner : ESRX-US : March 7, 2017
Mar-05-17 03:03PM  How Are Drug Prices Determined? at Motley Fool
Mar-03-17 04:13PM  Gilead Executive Says Pharmacy Benefit Managers Keep Prices High
Mar-01-17 03:52PM  Express Scripts opposes drug benefit clawbacks: Bloomberg at bizjournals.com
Feb-28-17 05:00PM  Obamacare plans' drug spending rose faster than other plans in 2016 - Express Scripts
05:00PM  High Drug Prices Frustrate Government-Sponsored Health Programs, According to New Express Scripts Drug Trend Insights PR Newswire
12:15PM  Horizon (HZNP) Misses on Earnings in Q4, View Disappoints
Feb-22-17 08:15AM  Post Earnings Coverage as Express Scripts' Adjusted EPS Gained 21%; Adjusted EBITDA per Adjusted Claim up 14% Accesswire
Feb-21-17 12:07PM  Express Scripts Holding Co. :ESRX-US: Earnings Analysis: 2016 By the Numbers : February 21, 2017
07:10AM  Express Scripts Holding Co. breached its 50 day moving average in a Bullish Manner : ESRX-US : February 21, 2017
06:35AM  [$$] Express Scripts: A Unique PBM at Barrons.com
Feb-18-17 01:04PM  EXPRESS SCRIPTS HOLDING CO. Financials
01:24AM  [$$] Merger's Collapse Could Boost Anthem Stock at Barrons.com
Feb-17-17 09:30AM  The Zacks Analyst Blog Highlights: Merck, PNC Financial, Express Scripts, VeriSign and Martin Marietta
09:26AM  Express Scripts Holding Co. :ESRX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017
Feb-16-17 04:11PM  Express Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017 PR Newswire
01:50PM  Q4 Earnings Season Scorecard & Top Analyst Reports
01:43PM  We dug into the drug company Martin Shkreli sold out to the feds, and man is it ugly
10:10AM  Company News for February 16, 2017
08:53AM  Masimo Gets CE Mark for RRp on MightySat Rx Pulse Oximeter
Feb-15-17 03:31PM  Edited Transcript of ESRX earnings conference call or presentation 15-Feb-17 1:30pm GMT
12:02PM  Express Scripts: Rx For Earnings Growth
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe. It operates in two segments, PBM and Other Business Operations. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; and Express Scripts SafeGuardRxSM, a suite of solutions targeting the medication classes that pose a budgetary threat to its clients. The Other Business Operations segment distributes pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides consulting services, such as design, implementation, and project management for pharmaceutical and biotechnology manufacturers to collect scientific evidence to guide the use of medicines. The company serves care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2016, it operated four automated dispensing home delivery pharmacies; one non-automated dispensing home delivery pharmacy; and one non-dispensing home delivery pharmacy, as well as various non-dispensing order processing and patient contact centers, specialty drug pharmacies, and fertility pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Paz GeorgeDirectorMar 03Option Exercise49.50174,3868,631,2351,060,362Mar 07 04:32 PM
Houston ChristineExecutive VP & COOMar 03Option Exercise49.5010,742531,67566,427Mar 07 06:14 PM
Neville EverettSr VP-Supply Chain & SpecialtyMar 01Sale70.162,352165,0168,935Mar 02 04:29 PM
Neville EverettSr. VP, Sup. Chain & SpecialtyJan 03Sale69.411,12377,94712,712Jan 05 04:01 PM
Miller Steven BSr. VP & Chief Med. OfficerNov 09Option Exercise49.5021,7981,078,89256,615Nov 14 04:02 PM
Anderson Phyllis S.Sr. VP & Ch. Marketing OfficerNov 09Sale74.7464247,9838,173Nov 14 04:01 PM
Miller Steven BSr. VP & Chief Med. OfficerNov 09Sale75.0221,7981,635,35134,817Nov 14 04:02 PM
MYERS WOODROW A JRDirectorSep 14Option Exercise56.0312,036674,35125,788Sep 16 04:47 PM
MYERS WOODROW A JRDirectorSep 14Sale70.4012,036847,38313,752Sep 16 04:47 PM
McGinnis Christopher AVP, Controller & Ch. Acct. OffSep 12Sale70.771,785126,3243,170Sep 13 04:51 PM
Mergenthaler FrankDirectorMay 27Option Exercise30.834,748146,38126,677May 31 04:04 PM
Neville EverettSenior VP, Supply ChainMay 10Sale74.1180059,28813,835May 11 04:01 PM
MAC MAHON THOMAS PDirectorApr 29Option Exercise30.8313,128404,73655,689May 03 04:06 PM
MAC MAHON THOMAS PDirectorApr 29Sale73.935,482405,30150,207May 03 04:06 PM